Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3K?/6 dual inhibitor

被引：3

作者：

Liang, Xiaofei ^{[1
,2
]}

Deng, Maoqing ^{[1
,2
,3
]}

Zou, Fengming ^{[1
,2
]}

Qi, Ziping ^{[1
,2
]}

Wang, Chun ^{[1
,3
]}

Liu, Juan ^{[1
,2
]}

Liu, Qingwang ^{[1
,2
]}

Wang, Beilei ^{[1
,2
]}

Qi, Shuang ^{[1
,2
]}

Ge, Juan ^{[1
,3
]}

Yu, Hongwei ^{[1
,3
]}

Wang, Aoli ^{[1
,2
]}

Liu, Qingsong ^{[1
,2
,3
,4
,5
]}

Liu, Jing ^{[1
,2
,3
,4
,5
]}

机构：

[1] Chinese Acad Sci, Inst Hlth & Med Technol, Hefei Inst Phys Sci, Anhui Prov Key Lab Med Phys & Technol, Hefei 230031, Anhui, Peoples R China

[2] Chinese Acad Sci, Hefei Canc Hosp, Hefei 230031, Anhui, Peoples R China

[3] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China

[4] Precis Med Res Lab Anhui Prov, Hefei 230088, Anhui, Peoples R China

[5] Chinese Acad Sci, Hefei Inst Phys Sci, Hefei 230031, Anhui, Peoples R China

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 260卷

基金：

中国国家自然科学基金;

关键词：

PI3K-GAMMA; INFLAMMATION; RESISTANCE; PI3K-DELTA; ISOFORM;

D O I：

10.1016/j.ejmech.2023.115768

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Phosphoinositol 3-kinases (PI3Ks) & gamma; and 6 are primarily expressed in leukocytes and play crucial roles in regulation of the immune system. Dual inhibition of PI3K & gamma;/6 has emerged as an effective approach to regulate the tumor microenvironment. Here, we report the exploration of structure-activity relationship optimization which led to the discovery of a potent PI3K & gamma;/6 dual inhibitor 15u (IHMT-PI3K-455). 15u exhibits strong potency in biochemical and cellular assays and it repolarizes M2 phenotype toward M1 phenotype in THP-1 and BMDM macrophages. In addition, it shows suitable in vivo properties as demonstrated through pharmacokinetic studies in rats and pharmacodynamics properties in a MC38 xenograft model.

引用

页数：16

共 50 条

[21] HETEROCYCLIC SYNTHESIS WITH NITRILES - SYNTHESES OF SOME NOVEL PYRAZOLO[1,5-A]PYRIMIDINE AND PYRROLO[2',3'-3,4]PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES
ABDELRAZEK, FM
JOURNAL FUR PRAKTISCHE CHEMIE, 1989, 331 (03): : 475 - 478
[22] Discovery of 3-pyrazolyl-substituted pyrazolo[1,5-a]pyrimidine derivatives as potent TRK inhibitors to overcome clinically acquired resistance
Gong, Yi
Wu, Feng-Xu
Wang, Ming-Shu
Xu, Hong-Chuang
Zhuo, Lin-Sheng
Yang, Guang-Fu
Huang, Wei
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 241
[23] Discovery of fluoroquinolone derivatives as potent, selective inhibitors of PI3Kγ
Sha, Shao
Han, Hong-Wei
Gao, Fei
Liu, Tian-Bao
Li, Zhen
Xu, Chi
Zhong, Wei-Qing
Zhu, Hai-Liang
MEDCHEMCOMM, 2015, 6 (11) : 2029 - 2035
[24] Discovery of novel pyrido[3,2-d]pyrimidine derivatives as selective and potent PI3Kδ inhibitors
Bai, Huanrong
Sun, Jiajia
Lei, Hao
Zhang, San-Qi
Yuan, Bo
Ma, Mengyan
Xin, Minhang
DRUG DEVELOPMENT RESEARCH, 2023, 84 (08) : 1709 - 1723
[25] Discovery of a pyrazolo[1,5-a] pyrimidine derivative (MT-3014) as a highly selective PDE10A inhibitor via core structure transformation from the stilbene moiety
Koizumi, Yuuki
Tanaka, Yoshihito
Matsumura, Takehiko
Kadoh, Yoichi
Miyoshi, Haruko
Hongu, Mitsuya
Takedomi, Kei
Kotera, Jun
Sasaki, Takashi
Taniguchi, Hiroyuki
Watanabe, Yumi
Takakuwa, Misae
Kojima, Koki
Baba, Nobuyuki
Nakamura, Itsuko
Kawanishi, Eiji
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (15) : 3440 - 3450
[26] Discovery of AZD8835, a potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of PIK3CA-dependent cancers
Barlaam, Bernard
Cosulich, Sabina
Delouvrie, Benedicte
Fitzek, Martina
Germain, Herve
Green, Stephen
Harris, Craig S.
Hudson, Kevin
Lambert-van der Brempt, Christine
Lamorlette, Maryannick
Antoine, Le Griffon
Morgentin, Remy
Ouvry, Gilles
Page, Ken
Pasquet, Georges
Ruston, Linette
Saleh, Twana
Vautier, Michel
Ward, Lara
CANCER RESEARCH, 2015, 75
[27] Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ
Allen, Rodger A.
Brookings, Daniel C.
Powell, Mark J.
Delgado, Jean
Shuttleworth, Lindsay K.
Merriman, Mark
Fahy, Ian J.
Tewari, Roohi
Silva, John P.
Healy, Louise J.
Davies, Gareth C. G.
Twomey, Breda
Cutler, Rona M.
Kotian, Apoorva
Crosby, Andrea
McCluskey, Gillian
Watt, Gillian F.
Payne, Andrew
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (03): : 429 - 440
[28] Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα
Nacht, Mariana
Qiao, Lixin
Sheets, Michael P.
St. Martin, Thia
Labenski, Matthew
Mazdiyasni, Hormoz
Karp, Russell
Zhu, Zhendong
Chaturvedi, Prasoon
Bhavsar, Deepa
Niu, Deqiang
Westlin, William
Petter, Russell C.
Medikonda, Aravind Prasad
Singh, Juswinder
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (03) : 712 - 721
[29] Selective inhibition of c-Myc/Max dimerization by a pyrazolo[1,5-a]-pyrimidine
Kiessling, Anke
Wiesinger, Rita
Sperl, Bianca
Berg, Thorsten
CHEMMEDCHEM, 2007, 2 (05) : 627 - +
[30] Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance
Fu, Xiang-Jing
Li, Na
Wu, Ji
Wang, Zi-Yue
Liu, Rui-Rui
Niu, Jin-Bo
Taleb, Mohammad
Yuan, Shuo
Liu, Hong-Min
Song, Jian
Zhang, Sai-Yang
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277

← 1 2 3 4 5 →